Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
130 participants
INTERVENTIONAL
2026-01-01
2027-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of a Transcutaneous Bilirubinometer
NCT01622699
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
NCT03195998
Transcutaneous Bilirubinometry in Neonates
NCT01422655
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
NCT01944696
BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
NCT03942757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transcutaneous bilirubinometry
in this arm the bilirubin level to monitor the effect of phototherapy will be measured through transcutaneous mbiirubinometry
Transcutaneous bilirubinometry
use of transcutaneous bilirubinometry a non-invasieve measurement of skin bilirubin levels
serum bilirubin
In this arm the bilirubin level to monitor the effect of phototherapy wil be measured through measurements of serum bilirubin obtained through blood draws
Serum bilirubin
use of blood draws to measure serum bilirubin level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous bilirubinometry
use of transcutaneous bilirubinometry a non-invasieve measurement of skin bilirubin levels
Serum bilirubin
use of blood draws to measure serum bilirubin level
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* exchange transfusion
0 Days
2 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Princess Amalia Children's Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jolita Bekhof
MD PhD Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jolita Bekhof, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
1971
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isala Klinieken
Zwolle, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.